À±¹Î¿ë(Yoon Min-Yong) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °ºÏ»ï¼ºº´¿ø ³»°úÇб³½Ç
¼Ûâ¼®(Song Chang-Seok) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °ºÏ»ï¼ºº´¿ø ³»°úÇб³½Ç
¼¹ÌÇØ(Seo Mi-Hae) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °ºÏ»ï¼ºº´¿ø ³»°úÇб³½Ç
±è¹ÎÀç(Kim Min-Jae) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °ºÏ»ï¼ºº´¿ø Ç÷¾×Á¾¾ç³»°ú
¿ÀÅÂÀ±(Oh Tae-Yun) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °ºÏ»ï¼ºº´¿ø ÈäºÎ¿Ü°úÇб³½Ç
Àå¿îÇÏ(Jang Un-Ha) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °ºÏ»ï¼ºº´¿ø ÈäºÎ¿Ü°úÇб³½Ç
°ûÇöÁÖ(Kwag Hyon-Joo) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °ºÏ»ï¼ºº´¿ø ¿µ»óÀÇÇаúÇб³½Ç
±èÈñ¼º(Kim Hee-Sung) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °ºÏ»ï¼ºº´¿ø º´¸®°úÇб³½Ç
Àӽÿµ(Lim Si Young) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °ºÏ»ï¼ºº´¿ø È£Èí±â³»°ú
ÀÓ¼º¿ë(Lim Seong-Yong) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °ºÏ»ï¼ºº´¿ø È£Èí±â³»°ú
À̼º¼¼(Lee Seung-Sae) - ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ °ºÏ»ï¼ºº´¿ø Ç÷¾×Á¾¾ç³»°ú
Abstract
Breast metastases from an extramammary primary tumor are very rare and the prognosis for such patients is generally poor. We report here on a case of a 42-year-old female with metastasis of non-small cell lung cancer to the breast, and she is now being followed up on an outpatient basis. In 2004, she presented with a solitary pulmonary nodule in the left lung, and this lesion had been noted to have gradually increased in size over time. The final pathological diagnosis was adenocarcinoma, and the diagnosis was made by performing percutaneous needle aspiration and lobectomy of the left upper lobe. Adjuvant chemotherapy and radiotherapy were given. Unfortunately, a nodule in the left breast was noted three years later, and metastatic non-small-cell lung cancer to the breast was diagnosed by excisional biopsy. Making the correct diagnosis to distinguish a primary breast carcinoma from a metastatic one is important, because the therapeutic plan and outcome for these two types of cancer are quite different.
Ű¿öµå
Non-small cell lung carcinoma, Metachronous breast metastasis, Adenocarcinoma
KMID :
0939920100420030172
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
Making the correct diagnosis to distinguish a primary breast carcinoma from a metastatic one is important, because the therapeutic plan and outcome for these two types of cancer are quite different.